SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-305464
Filing Date
2021-10-22
Accepted
2021-10-22 16:27:53
Documents
1
Group Members
ATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM OPPORTUNITIES ASSOCIATES IV GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES IV LPJEFFREY A. FERRELL

Document Format Files

Seq Description Document Type Size
1 SC 13G d234965dsc13g.htm SC 13G 101456
  Complete submission text file 0001193125-21-305464.txt   103195
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-90830 | Film No.: 211340823
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 FIFTH AVENUE FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE FLOOR 18 NEW YORK NY 10017 212-402-6925
Athyrium Opportunities IV Acquisition 2 LP (Filed by) CIK: 0001888848 (see all company filings)

IRS No.: 872028841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G